AMY HOBSON: Open Payments
NPI 1275866980 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 41 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $524 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $151 |
| AstraZeneca Pharmaceuticals LP | 8 | $141 |
| Lilly USA, LLC | 5 | $108 |
| ABBVIE INC. | 3 | $86 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| SHIELD THERAPEUTICS INC | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Electromed, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $19 |
Products named: MOUNJARO, AIRSUPRA, Ozempic, QULIPTA, Wegovy, ACCRUFER, TRELEGY ELLIPTA, SPRAVATO.
Industry payments across OK — which companies pay providers there.
